Skip to main content
FinSpry Logo
FinSpry
PTCT logo
PTCT
(NASDAQ)
PTC Therapeutics, Inc.
$78.40-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

PTC Therapeutics (PTCT) Stock Price & Financial Analysis

PTC Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$77.53 - $80.56
52-Week High$90.87
52-Week Low$43.18
Open$79.50
Volume1.14M
Average Volume (3M)2.32M
Market Cap6.48B
Shares Outstanding82.52M
Price to Sales (P/S)7.83
Price to Book (P/B)-35.90
EV/EBITDA-50.20
Revenue (TTM)827.11M
Net Income (TTM)-186.73M
Free Cash Flow (TTM)-516.78M
EPS (TTM)$-2.27
Profit Margin-22.58%
Operating Margin-8.18%
50-Day MA$76.25
200-Day MA$72.53
52-Week Change61.80%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About PTC Therapeutics

What is the current stock price for PTCT?

As of the latest trading session, PTCT stock trades at $78.50. The 52-week range is $43.18–$90.87, with a day range of $77.53–$80.56.

What is the P/E ratio for PTCT?

The P/E ratio (Price-to-Earnings) for PTCT is shown in the Key Statistics section. This valuation metric helps compare PTC Therapeutics, Inc. to industry peers.

Does PTCT pay dividends?

PTC Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PTCT?

Based on 10 analysts, the consensus for PTCT is Buy.

What is the market cap of PTCT?

PTC Therapeutics's market capitalization is $6.48B, classifying it as a mid-cap company. PTC Therapeutics operates in the Healthcare sector within the Biotechnology industry.